Immunotherapy drug pembrolizumab improves outcomes for patients with soft
tissue sarcoma
-
Addition of the immunotherapy drug pembrolizumab to standard of care for
patients with advanced soft tissue sarcoma of the limb significantly
improved dise...
Friday, October 15, 2021
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment